Skip to main content

FDA Okays Generic Nasal Spray To Treat Opioid Overdose

FDA Okays Generic Nasal Spray To Treat Opioid Overdose

FDA Okays Generic Nasal Spray To Treat Opioid Overdose

Introduction

On Friday, April 19, the Food and Drug Administration (FDA) granted final approval to the first generic version of naloxone hydrochloride nasal spray, also known as Narcan, to treat opioid overdoses.

The newly-approved spray is a Teva Pharmaceuticals product and had received tentative approval by the FDA in June 2018. Generic injectable naloxone products were available in the market for years; however, this was the first time a generic naloxone nasal spray was approved for use in a community where individuals using them to treat overdose, do not require any medical training. The drug can be sprayed into one nostril while the patient is lying on his or her back, and can be repeated if necessary. The agency also plans to take additional measures, to review new generic drug applications for treating opioid overdose, and to come up with a plan of action to help facilitate an over-the-counter naloxone product.

As per reports by the Centers for Disease Control and Prevention (CDC), almost 400,000 people died owing to opioid addiction and overdose between 1999 and 2017.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.